Nimodipine pulse sustained release mircopill preparation and preparing method thereof
A technology of sustained-release pellets and pulses, which is applied in the direction of pharmaceutical formulations, medical preparations containing active ingredients, cardiovascular system diseases, etc. problems, to achieve stable blood drug concentration, reduce side effects, and reduce the number of medications
Active Publication Date: 2010-11-24
SHENZHEN SOUTH CHINA PHARMA
View PDF0 Cites 0 Cited by
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
However, due to the large daily dosage of nimodipine, which is almost insoluble in water, and the particularity of other physical and chemical properties, the release rate of the drug is difficult to control, and it is difficult to make a pulse sustained-release preparation that is administered once a day and has time characteristics.
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View moreImage
Smart Image Click on the blue labels to locate them in the text.
Smart ImageViewing Examples
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
Embodiment 2
Embodiment 3
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More PUM
Login to View More
Abstract
The invention relates to a pulsed sustained-release pellet comprising nimodipine and a preparation method is also provided. The sustained-release pellet comprises: one of gastric-dissolved and medicines containing sustained-release pellets and enteric-coated and medicines containing sustained-release pellets, or the combination. The preparation method is that: making medicines containing pellets using nimodipine and excipents, coating the medicines containing pellets with the gastric coating or the enteric coating, mixing the sustained-release pellets coated with gastric coating and enteric coating in proportion and putting the sustained-release pellets into capsules or tabletting. The pulsed sustained-release pellet of the invention has a special release behavior and needs to be taken only once per day. The release curve agrees well with the disease circadian rhythm of cerebrovascular disease patients, playing a role of the best prevention and treatment.
Description
Nimodipine pulse sustained-release pellet preparation and preparation method thereof technical field The invention relates to the technical field of pharmaceutical preparations, in particular to a preparation method of pulse sustained-release pellets containing nimodipine. technical background Nimodipine is a dihydropyridine calcium ion antagonist, which is highly selective for brain tissue receptors and easily penetrates the blood-brain barrier. By effectively preventing calcium ions from entering cells and inhibiting smooth muscle contraction, the purpose of releasing vascular smooth muscle is achieved, thereby protecting brain neurons, stabilizing their function, increasing cerebral blood perfusion, improving cerebral blood supply, and increasing tolerance to hypoxia. At present, it is widely used in cerebrovascular disease and nootropic drugs in clinical practice. The main indications are: (1) prevention and treatment of subarachnoid hemorrhage and cerebral vasospasm; ...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More Application Information
Patent Timeline
Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K9/16A61K9/22A61K9/52A61K31/4422A61P9/10A61P9/12A61P25/06
Inventor 巩洪刚张四喜张翠娟邓树海
Owner SHENZHEN SOUTH CHINA PHARMA
Who we serve
- R&D Engineer
- R&D Manager
- IP Professional
Why Patsnap Eureka
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com